Sign In
Buy DD
$48.26
+1.42 (+3.03%)
At Close: Jun 12, 2026
DuPont Expands Healthcare Manufacturing Site in Costa Rica, Adding Sterile Packaging Capacity
09:00am, Thursday, 05'th Jun 2025
The 16,000-square-foot expansion enhances DuPont's global sterile operations, increases the capacity of the manufacturing site's existing medical tubing operations, and enables Costa Rica's first-ever
DuPont Powers AI and Next-Gen Electronics with Advanced Interconnect Innovations at JPCA Show 2025
09:00pm, Tuesday, 03'rd Jun 2025
TOKYO , June 3, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced its participation in the Total Solution Exhibition for Electronic Equipment 2025 (JPCA Show 2025), taking place from June 4-6 at
Here's Why You Should Hold DuPont Stock in Your Portfolio for Now
08:41am, Friday, 30'th May 2025
Innovation, cost savings and healthcare acquisitions support DD as it navigates weak demand and hefty separation costs in 2025.
DOW vs. DD: Which Chemical Giant Deserves a Spot in Your Portfolio?
08:15am, Thursday, 29'th May 2025
Dow tackles weak demand with cost cuts and cash actions, while DuPont gains from acquisitions in healthcare and innovation.
DuPont Achieves 100% Renewable Electricity in EU Operations
10:06am, Wednesday, 28'th May 2025
DD hits 100% renewable electricity for EU operations, marking a major step toward its 2050 net-zero emissions goal using RECs and solar installations.
DuPont Achieves 100 Percent Renewable Electricity Across its European Union Operations
09:00am, Tuesday, 27'th May 2025
Company marks significant progress towards 2050 climate goals WILMINGTON, Del. , May 27, 2025 /PRNewswire/ -- DuPont (NYSE: DD) today announced 100 percent of its grid electricity is from renewable so
DuPont Launches AmberChrom TQ1 Resin for Biopharma Applications
09:31am, Friday, 23'rd May 2025
DD launches AmberChrom TQ1 resin, boosting oligonucleotide and peptide purification with high capacity, purity, and scalability.
DuPont Expands Bioprocessing Portfolio with Launch of DuPont™ AmberChrom™ TQ1 Chromatography Resin
09:00am, Thursday, 22'nd May 2025
Agarose-based chromatography resin supports purification of oligonucleotides and peptides for biopharma applications WILMINGTON, Del. , May 22, 2025 /PRNewswire/ -- DuPont has expanded its bioproces
Pessimism Overdone? 2 Recession-Resistant Dividend Stocks To Reward Long-Term Investors
07:06am, Wednesday, 21'st May 2025
The market has recovered most of its losses from last month's correction, and many quality stocks appear expensive again, prompting some investors to wait for another correction. DuPont de Nemours, In
DuPont and Epicore Biosystems Collaborate to Advance Worker Safety Through Smart Wearable Technology
12:21pm, Tuesday, 20'th May 2025
CAMBRIDGE, Mass. and WILMINGTON, Del.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DuPont de Nemours, Inc. - DD
09:00am, Friday, 16'th May 2025
NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of DuPont de Nemours, Inc. ("DuPont" or the "Company") (NYSE:DD). Such investors are a
DuPont Unveils Brand Identity for Qnity, Future Electronics Spin-Off
09:40am, Wednesday, 14'th May 2025
Qnity™ Branding Symbolizes the Power of Innovation and Partnership WILMINGTON, Del. , May 14, 2025 /PRNewswire/ -- DuPont (NYSE: DD) today unveiled the branding of Qnity, the planned independent Ele
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DuPont de Nemours, Inc. - DD
09:00am, Wednesday, 14'th May 2025
NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of DuPont de Nemours, Inc. ("DuPont" or the "Company") (NYSE:DD). Such investors are a
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of DuPont de Nemours, Inc. – DD
01:16pm, Tuesday, 13'th May 2025
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DuPont de Nemours, Inc. (“DuPont” or the “Company”) (NYSE: DD). Such investors are ad
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DuPont de Nemours, Inc. - DD
05:46pm, Monday, 12'th May 2025
NEW YORK , May 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DuPont de Nemours, Inc. ("DuPont" or the "Company") (NYSE: DD). Such investors are advised to
